ABOUT: Welcome to CRWENewswire, Stocks to Watch for Wednesday Dec. 28, 2011. I am Lynn Lumpkin. Mylan Inc - MYL - reported that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the FDA for its Abbreviated New Drug Application for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base), which are used to treat hypertension. The New York Times Co. - NYT - announced that it has entered into an agreement to sell its Regional Media Group, consisting of 16 regional newspapers, other print publications and related businesses, to Halifax Media Holdings LLC for $143 million in cash, subject to certain adjustments. and finally; Nanosphere Inc - NSPH - reported that it has received 510(k) clearance from the FDA for the Verigene Staphylococcus Blood Culture Nucleic Acid Test. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Lynn Lumpkin